B9DND0 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiasad25k3xgthjadet3t4ppvhyjczaex7ytqgie742gvezu73hk6a/metadata.json
IPFS of structure file: 
bafybeie2ocvxxfc7o65jrebcdqidql5vcx3uqfdy2ykizfaz3mqaly2bt4/AF-B9DND0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x0c3BD61770FeF3aB621008259DC933f6DfDc3882
First NFT owner address (bech32): 
genesis1psaav9mslme6kcsspqjemjfn7m0acwyzn4k57l
Current NFT ID #166921 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166921
Accession (UniProt):
B9DND0
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Staphylococcus carnosus (strain TM300)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B9DND0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B9DND0|HEM1_STACT Glutamyl-tRNA reductase OS=Staphylococcus carnosus (strain TM300) OX=396513 GN=hemA PE=3 SV=1 MHIIAISINHRTADVALREKVAFKADAIRESHLDLFETKSILENVILSTCNRTEVYAVADQIHTGRYYIQRFLARKFGLEVDEIKEMSEVFVGDEAVEHIFRVTAGLDSIVLGETQILGQMRDAFFIAQEEGTTGTIFNHLFKQAITFAKRAHHETDIADNAVSVSYAAVELAKKVFGNLKSKHAVIVGAGEMSELSLLNLLGAGIDNITVVNRTKERAQQLAEKHQTQYADLSNLNELLVNADIVISSTSAQNYVITQEMMNNVLDQRRHEPMVLIDIAVPRDIDPAIELDMNVFSYDIDDLKGLVDANLRERQAAADQIAEQIPAEINEHNDWVNMLGVVPVIRALREKAMHIQQDTMDSIDRKLPDLSERERKVISKHTKSIINQMLKDPIKQAKELSNDKNSSEKLELFQNIFDIEAESEYKKSLAKKERKLSARHILGFE